Latest news
Why Bavarian Nordic (CPSE:BAVA) Could Be 36% Undervalued Following IMVANEX Child Approval - simplywall.stsimplywall.st · Sun, 09 Aug 2026 05:24:43 GMTBioInvent wins FDA Fast Track for BI-1808 after encouraging ovarian cancer data - AllSciAllSci · Fri, 07 Aug 2026 16:28:01 GMTBavarian Nordic Wins EU Approval to Expand Mpox/Smallpox Vaccine to Children as Young as 2 - BioPharm InternationalBioPharm International · Fri, 07 Aug 2026 15:55:43 GMTBioMarin discontinues rare disease drug; CSL and Arcturus split up - Endpoints NewsEndpoints News · Fri, 07 Aug 2026 15:08:00 GMTEU clears label expansion for Bavarian Nordic's Mpox vaccine to children as young as two - AllSciAllSci · Fri, 07 Aug 2026 13:40:45 GMTBavarian Nordic receives expanded EU approval for smallpox and mpox vaccine in children - medwatch.commedwatch.com · Fri, 07 Aug 2026 08:07:47 GMTFDA approves Moderna’s mRNA flu vaccine - BioPharma DiveBioPharma Dive · Thu, 06 Aug 2026 11:10:45 GMT